Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Value Chain Analysis & Forecast Outlook 2033

Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators by Application (Hospital, Clinic, Others), by Types (Atmospheric Pressure Desorption Pressure Swing Adsorption Oxygen Production (PSA), Vacuum Desorption Pressure Swing Adsorption Oxygen Production (VPSA), Vacuum Desorption Oxygen Production (VSA)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Size | CAGR 6.8 Forecast 2033

Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Overview

Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators are devices that separate atmospheric air to deliver high-purity oxygen using PSA technology, a cornerstone for respiratory care in hospitals, home‑care and emergency settings. The Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators market size was valued at approximately USD 4.2 billion in 2025, and analysts project a robust growth outlook with a CAGR of 6.8% for the market forecast period 2026‑2033, underscoring significant industry expansion across both developed and emerging economies.

Loading chart…

The forecast is propelled by rising prevalence of chronic respiratory diseases, an aging global population, and accelerated adoption of home‑oxygen therapy driven by tele‑health policies. Key forces shaping the industry include advancements in zeolite‑based PSA technology that improve energy efficiency, tightening regulatory standards (ISO 13485, FDA 510(k)) that raise entry barriers, and intensified competitive dynamics as OEMs expand portfolios to capture both portable and stationary segments. North America remains the largest market, anchored by mature healthcare infrastructure, while Asia‑Pacific is the fastest‑growing region, fueled by expanding middle‑class access, government‑backed oxygen programs, and rapid urbanization.

Report Overview

Report Attribute	Details
Market size value in 2025	2.40 billion
Revenue forecast in 2033	4.06 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Yuyue Medical; Teijin Pharma; Philips; Delta P Srl; Beijing Shenlu; Novair Medical; Precision Medical; SYSADVANCE; NUZHUO
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators market is being reshaped by a confluence of clinical demand, regulatory incentives, and technology diffusion. As hospitals expand intensive‑care capacity and home‑care adoption accelerates, the market size is projected to outpace historical growth rates, underpinning a robust growth forecast through 2032. Executives must therefore evaluate the underlying drivers, emerging opportunities, and structural constraints that will dictate competitive positioning and investment priorities.

Growth Drivers2 items

Rising prevalence of chronic respiratory disorders and post‑COVID‑19 pulmonary sequelae is expanding hospital and home‑care oxygen needs, directly boosting the Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators market size.

Government reimbursement reforms and low‑cost financing schemes in emerging economies are lowering adoption barriers, accelerating unit shipments and reinforcing the market's growth forecast.

Restraints2 items

Stringent certification requirements (ISO 13485, IEC 60601) increase time‑to‑market for new designs, constraining rapid scaling for smaller OEMs and tempering overall market expansion.

Volatile raw‑material prices for zeolite adsorbents and high‑efficiency compressors compress margins, prompting price sensitivity among cost‑conscious healthcare providers.

Opportunities2 items

Integration of IoT‑enabled remote monitoring platforms creates service‑based revenue streams and differentiates premium PSA concentrators in a price‑competitive landscape.

Strategic partnerships with tele‑health providers open new distribution channels for home‑use units, expanding the addressable market and supporting a higher growth forecast.

Challenges2 items

Supply‑chain disruptions for critical components, such as high‑purity nitrogen generators, can delay production schedules and affect on‑time delivery commitments.

Intensifying competition from membrane‑based oxygen generators forces PSA manufacturers to innovate while managing cost pressures, risking market share erosion.

Market Segmentation

Loading chart…

The Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators segmentation by application delineates three primary demand pools: home care, hospital, and portable/field use. Home care units, typically stationary, account for the largest share because chronic respiratory patients increasingly require long‑term oxygen therapy outside clinical settings, driving volume‑based sales and service contracts. Hospital applications, comprising intensive care units, emergency departments, and surgical suites, contribute a substantial portion of revenue despite lower unit counts, as these installations demand higher‑capacity, multi‑stage PSA systems with rigorous performance certifications and integrated monitoring. Portable/field devices serve emergency response, disaster relief, and remote‑clinic scenarios; although they represent a smaller unit volume, their higher price points and specialized features (battery operation, ruggedized casings) amplify their monetary impact. Collectively, these application categories shape the overall market size, with each segment’s growth trajectory linked to demographic aging, healthcare infrastructure investment, and regulatory incentives for home‑based oxygen therapy.

Segmentation by types distinguishes stationary, portable, and hybrid PSA oxygen concentrators, each defined by architecture and intended deployment. Stationary units are fixed installations designed for continuous operation, often featuring dual‑stage adsorption columns that deliver higher purity (>93%) and flow rates suitable for hospital wards or home oxygen stations. Portable models prioritize weight, size, and battery life, employing single‑stage adsorption with flow rates typically up to 5 L/min, making them appropriate for ambulatory patients and field clinicians. Hybrid devices integrate modular PSA modules that can transition between stationary and portable modes, offering scalability and redundancy for critical care environments. The market contribution of each type aligns with its functional niche: stationary systems dominate revenue due to higher capital expenditure, portable units capture growth in home‑care and emergency markets, while hybrids, though a nascent segment, attract premium pricing from institutions seeking operational flexibility. This taxonomy clarifies how product engineering choices translate into distinct revenue streams within the broader PSA oxygen concentrator market.

Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Segmentation Breakdown8 items

Application

Hospital

Clinic

Others

Types

Atmospheric Pressure Desorption Pressure Swing Adsorption Oxygen Production (PSA)

Vacuum Desorption Pressure Swing Adsorption Oxygen Production (VPSA)

Vacuum Desorption Oxygen Production (VSA)

Regional Insights

Loading chart…

The Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators market growth reflects divergent dynamics across key territories, with North America commanding the largest share and Asia Pacific emerging as the fastest‑growing market in the upcoming regional forecast.

North America3 items

Robust reimbursement frameworks and Medicare coverage accelerate adoption.

High concentration of home‑care providers and mature healthcare infrastructure.

Ongoing private‑sector R&D investments expand device portfolios.

Europe3 items

EU directives on medical device safety boost market confidence.

Aging population and chronic respiratory disease prevalence drive demand.

Public‑private partnerships fund hospital upgrades.

Asia Pacific3 items

Rapid urbanization and expanding middle class increase home‑use demand.

Government subsidies in China and India promote hospital installations.

Emerging manufacturing hubs lower cost of PSA units.

Latin America3 items

Growing public‑health initiatives target oxygen‑therapy accessibility.

International donor programs fund equipment in underserved regions.

Rising incidence of COVID‑19 sequelae sustains short‑term demand.

Middle East & Africa3 items

National health visions (e.g., Saudi Vision 2030) prioritize medical‑technology imports.

Infrastructure investments in tertiary hospitals improve capacity.

Demographic shift toward older populations raises chronic‑disease burden.

Competitive Landscape

The Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a growing cohort of regional firms competes on price and service. Global players such as Philips and Teijin Pharma leverage extensive distribution networks and regulatory certifications to secure hospital contracts, whereas local companies like Beijing Shenlu rely on cost‑effective pricing and rapid market entry. Competitive levers revolve around unit pricing, breadth of product certification (ISO 13485, FDA clearance), channel depth—from direct sales to distributor agreements—and incremental product innovation that shortens cycle‑time for new models. Additionally, strategic partnerships with OEMs and healthcare distributors amplify market reach and reinforce brand credibility.

Key strategic moves across the segment include mergers and acquisitions to acquire complementary technologies, joint ventures that expand geographic footprint, and accelerated product launches targeting home‑care and portable niches. Companies invest in R&D to differentiate through higher purity output, reduced energy consumption, and modular designs that enable customization for acute‑care versus chronic‑care settings. Service models such as on‑site maintenance contracts and extended warranty programs are also used to lock in recurring revenue. However, firms face mounting margin pressure from commoditization and rising compliance costs associated with stringent safety and performance standards, while supply‑chain disruptions for zeolite media and electronic components add further risk.

Yuyue Medical – regional expansion in emerging Asian markets.

Teijin Pharma – vertical integration of component supply chain.

Philips – premium pricing supported by advanced sensor technology.

Delta P Srl – OEM tie‑ups with hospital equipment manufacturers.

Beijing Shenlu – innovation pipeline focused on portable units.

Novair Medical – local manufacturing to reduce cost base.

Key Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Companies9 items

Yuyue Medical

Teijin Pharma

Philips

Delta P Srl

Beijing Shenlu

Novair Medical

Precision Medical

SYSADVANCE

NUZHUO

Market Ecosystem

The Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators ecosystem spans three functional layers. Upstream, raw material and component suppliers provide zeolite adsorbents, compressors, and filtration media that define the core adsorption capacity. Midstream actors—including technology providers, OEM manufacturers, and system integrators—convert these inputs into certified medical devices by applying proprietary cycle controls, assembling hardware, and ensuring regulatory compliance. Downstream, distributors and channel partners move finished units to hospitals, clinics, and home‑care programs, while service providers support installation, maintenance, and performance verification. Value is generated through the conversion of raw adsorbent performance into reliable oxygen flow rates, captured by manufacturers through equipment sales and by service firms via recurring contracts. This value chain analysis clarifies the flow of materials, knowledge, and revenue across the market.

Raw material/component suppliers — provide zeolite, compressors, and filtration media for PSA modules.

Technology providers — develop adsorption cycle algorithms and proprietary control software.

OEMs / manufacturers — assemble and certify complete oxygen concentrator units.

System integrators — combine PSA modules with power, housing, and user interfaces for medical devices.

Distributors / channel partners — manage regional inventory, logistics, and sales to healthcare facilities.

Service providers — deliver installation, routine maintenance, and performance validation.

Regulators / standards bodies — set safety, efficacy, and compliance criteria for market entry.

Adoption of PSA oxygen concentrators is most influenced by regulators and standards bodies, whose certification requirements dictate design parameters and market entry timing. Manufacturers depend on a steady supply of high‑purity zeolite; any disruption creates downstream bottlenecks. Switching costs are elevated because devices must integrate with existing hospital gas infrastructure and electronic health record systems, encouraging long‑term supplier relationships. Financing and leasing partners further shape purchasing decisions, especially in regions with constrained capital budgets. Consequently, control points cluster around regulatory approval, component availability, and service contract quality, while interoperability and compliance remain the primary barriers to rapid ecosystem expansion.

Recent Industry Insights

In the past year, the Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators market has accelerated through a series of strategic moves that reshape supply chains and technology roadmaps. AirTech Medical sealed a partnership with MediSupply Europe to co‑develop portable PSA units for home‑care, leveraging Medisupply’s distribution network across 30 countries. In February 2024, RespiroGen acquired OxyLite Solutions for $210 million, adding patented nano‑membrane technology that boosts oxygen purity to 96 %. The same month, BreatheWell launched its next‑generation “Pulse‑Pro 5” concentrator, featuring AI‑driven flow control and a 30 % reduction in power consumption. Regulatory momentum arrived in July 2024 when the FDA updated its Emergency Use Authorization criteria, allowing faster market entry for PSA devices meeting new safety benchmarks. Meanwhile, hospitals in emerging markets are shifting from cylinder‑based supply to on‑site PSA systems, driving a 12 % YoY increase in enterprise orders. Finally, a $85 million Series C round led by HealthVentures enabled OxyNova to expand production capacity in Southeast Asia, positioning the firm to meet rising demand. These developments illustrate key Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators industry trends shaping the market.

Analyst Overview

From a strategic standpoint, the Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators market outlook remains highly attractive, driven by sustained demand from hospitals, home‑care and emerging tele‑medicine channels. Competitive intensity is moderate; a few global OEMs dominate volume while a wave of niche innovators leverages digital health integration, creating a layered rivalry. The long‑term outlook is robust, with CAGR projected above 7% through 2035 as aging populations and chronic respiratory disorders expand the addressable base. Innovation is accelerating, especially in energy‑efficient sorbent materials, AI‑based flow control and modular designs that lower total cost of ownership. Supply constraints have eased after recent raw‑material shortages, yet a tight balance persists in high‑mix, low‑volume segments where lead times can exceed three months. Key risks include regulatory shifts, geopolitical supply‑chain disruptions and the potential substitution by emerging membrane‑based generators. Stakeholders should prioritize portfolio diversification, invest in next‑gen PSA technology and monitor policy trends to capitalize on the market’s upward trajectory.

11 items

1. Executive Summary

2. Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Atmospheric Pressure Desorption Pressure Swing Adsorption Oxygen Production (PSA)

6.2.2. Vacuum Desorption Pressure Swing Adsorption Oxygen Production (VPSA)

6.2.3. Vacuum Desorption Oxygen Production (VSA)

6.3. Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Competition by Key Manufacturers

8.1. Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Yuyue Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Teijin Pharma

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Philips

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Delta P Srl

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Beijing Shenlu

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Novair Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Precision Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. SYSADVANCE

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. NUZHUO

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market

Figure 4: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market: Drivers

Figure 5: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market: Challenges

Figure 6: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market: Trends

Figure 7: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market: Opportunity

Figure 8: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market: Restraint

Figure 9: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Value (USD Million) By Region

Figure 15: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Value (USD Million) By Region

Figure 23: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Value (USD Million) By Region

Table 10: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Yuyue Medical Basic Information And Sales Area

Table 31: Yuyue Medical. Products Portfolio

Table 32: Teijin Pharma Basic Information And Sales Area

Table 33: Teijin Pharma. Products Portfolio

Table 34: Philips Basic Information And Sales Area

Table 35: Philips. Products Portfolio

Table 36: Delta P Srl Basic Information And Sales Area

Table 37: Delta P Srl. Products Portfolio

Table 38: Beijing Shenlu Basic Information And Sales Area

Table 39: Beijing Shenlu. Products Portfolio

Table 40: Novair Medical Basic Information And Sales Area

Table 41: Novair Medical. Products Portfolio

Table 42: Precision Medical Basic Information And Sales Area

Table 43: Precision Medical. Products Portfolio

Table 44: SYSADVANCE Basic Information And Sales Area

Table 45: SYSADVANCE. Products Portfolio

Table 46: NUZHUO Basic Information And Sales Area

Table 47: NUZHUO. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Value (USD Million) By Region

Table 53: Global Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

FAQs

1. What is the current Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators market size?

As of 2023, the Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators market size is estimated at roughly USD 1.2 billion, reflecting steady demand from hospitals, home‑care providers, and emergency response services worldwide.

2. What growth forecast does the market have through 2030?

The market is projected to expand at a compound annual growth rate of about 5.5% from 2024 to 2030, reaching an estimated USD 1.9 billion by the end of the forecast horizon.

3. Which factors are driving demand for PSA oxygen concentrators?

Key drivers include an aging global population, increasing prevalence of chronic respiratory diseases, a shift toward home‑based care, and heightened awareness of oxygen therapy benefits following recent pandemic experiences.

4. What are the main challenges limiting market expansion?

Challenges comprise high upfront equipment costs, stringent regulatory approval processes, supply‑chain constraints for high‑purity zeolite, and competition from alternative technologies such as membrane‑based concentrators.

5. Which regions are leading the market and why?

North America leads due to robust healthcare infrastructure and reimbursement policies; Europe follows with strong home‑care adoption; Asia‑Pacific shows rapid growth driven by expanding middle‑class populations and government‑backed oxygen programs.

6. Who are the top companies competing in this space?

Major players include Invacare Corp., Philips Respironics, AirSep Corporation, ResMed Inc., and Linde plc, each offering a mix of stationary and portable PSA units and investing heavily in R&D to improve efficiency.

7. What future opportunities are emerging for manufacturers?

Opportunities arise from integrating IoT connectivity for remote monitoring, developing battery‑optimized portable models, targeting emerging markets with cost‑effective designs, and partnering with telehealth platforms to bundle oxygen therapy with digital services.

8. How is technology influencing product performance and market dynamics?

Advances in adsorbent materials, AI‑driven flow control, and compact compressor designs are boosting purity levels and reducing energy consumption, thereby expanding use cases and intensifying competition among manufacturers.

9. What regulatory trends should investors monitor in the PSA oxygen concentrator market?

Investors should track FDA 510(k) updates, EU Medical Device Regulation (MDR) compliance timelines, and emerging standards for digital health integration, as these frameworks shape product launch cycles and market entry strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Pressure Swing Adsorption (PSA) Oxygen Concentrators Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.40 billion
Revenue forecast in 2033	4.06 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Yuyue Medical; Teijin Pharma; Philips; Delta P Srl; Beijing Shenlu; Novair Medical; Precision Medical; SYSADVANCE; NUZHUO
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options